百胜中国(09987)发布公告，于2025年8月1日该公司斥资631.3万港元回购1.72万股，回购价格为每股 364.8-369.6港元。 于2025年8月1日该公司斥资320万美元回购6.89万股，回购价格为每股46.10-46.77美元。 ...

Group 1 - The United States will implement "reciprocal tariffs" starting August 7, which may impact trade dynamics [1] - Key financial reports are expected from companies such as AMD, Micron Technology, Novo Nordisk, and Eli Lilly [1] - The 2025 World Robot Expo will open in Beijing, highlighting advancements in robotics [1] Group 2 - On August 4, the Eurozone's Sentix Investor Confidence Index and the U.S. factory orders for June will be released [2] - On August 5, China will publish the July S&P Global China PMI, and the U.S. will release the July ISM Non-Manufacturing Index [2] - On August 6, financial results from AMD, McDonald's, and Novo Nordisk will be disclosed [2] - On August 7, the U.S. will begin implementing "reciprocal tariffs," and the Bank of England will announce its policy interest rate [2] - On August 8, the U.S. is requesting a resolution between Russia and Ukraine by August 8 [2] - On August 9, China will release July CPI and PPI data [2]

Group 1 - Company announced a share buyback of 17,200 shares at a total cost of HKD 6.313 million on August 1, 2025, with a price range of HKD 364.8 to HKD 369.6 per share [1] - Company also announced a buyback of 68,900 shares at a total cost of USD 3.2 million on August 1, 2025, with a price range of USD 46.10 to USD 46.77 per share [1]

Core Viewpoint - Yum China (09987.HK) announced a share buyback on August 1, spending HKD 6.313 million to repurchase 17,200 shares [1] Group 1 - The total amount spent on the share buyback was HKD 6.313 million [1] - The number of shares repurchased was 17,200 [1]

Core Insights - In July, Hong Kong listed companies actively engaged in share buybacks, with a total buyback amount exceeding 10 billion HKD [1] Group 1: Buyback Activity - A total of 73 Hong Kong listed companies conducted share buybacks in July, repurchasing 808 million shares [1] - The total buyback amount reached 10.035 billion HKD [1] Group 2: Leading Companies - The top five companies by buyback amount were Tencent Holdings (3.503 billion HKD), AIA Group (2.704 billion HKD), HSBC Holdings (2.221 billion HKD), WuXi Biologics (597 million HKD), and Yum China (138 million HKD) [1] - These five companies accounted for over 90% of the total buyback amount in July [1] Group 3: Industry Distribution - The share buybacks were primarily concentrated in the sectors of internet technology, finance, healthcare, and non-essential consumer goods [1]

Core Viewpoint - Yum China (09987) announced a share buyback plan, indicating confidence in its financial health and future prospects [1] Group 1: Share Buyback Details - The company will repurchase 17,150 shares at a total cost of HKD 6.2745 million, with a price range of HKD 363.8 to 368 per share [1] - Additionally, the company will spend USD 320,000 to buy back 68,600 shares, with a price range of USD 46 to 46.86 per share [1]

智通财经APP讯，百胜中国(09987)发布公告，于2025年7月31日斥资627.45万港元回购股份1.715万股， 每股回购价格为363.8-368港元。 于同日，斥资320万美元回购股份6.86万股，每股回购价格为46-46.86美元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 百勝中國控股有限公司("本公司") 呈交日期： 2025年8月1日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 09987 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | ...

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates can be challenging due to associated risks and volatility. Yum China Holdings (YUMC) is highlighted as a promising growth stock based on its favorable growth metrics and Zacks Rank. Group 1: Earnings Growth - Yum China's historical EPS growth rate is 12.2%, with projected EPS growth of 7.3% this year, surpassing the industry average of 6.7% [5][4]. Group 2: Asset Utilization - Yum China has an asset utilization ratio (sales-to-total-assets ratio) of 1, indicating it generates $1 in sales for every dollar in assets, which is higher than the industry average of 0.97 [6]. Group 3: Sales Growth - The company's sales are expected to grow by 2.9% this year, compared to the industry average of 2.4% [7]. Group 4: Earnings Estimate Revisions - The current-year earnings estimates for Yum China have been revised upward, with the Zacks Consensus Estimate increasing by 0.5% over the past month [9][8]. Group 5: Overall Assessment - Yum China has achieved a Zacks Rank of 2 (Buy) and a Growth Score of A, positioning it well for potential outperformance in the growth stock category [10][11].

Performance Updates - 开拓药业-B (09939.HK) has completed patient enrollment for the Phase III clinical trial of KX-826 solution for androgenetic alopecia in adult males in China [2] - 李氏大药厂 (00950.HK) has received approval from the National Medical Products Administration for Socazolimab to be used in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer in mainland China [2] - 恒瑞医药 (01276.HK) has received approval for clinical trials of SHR-8068 injection, Adebali monoclonal antibody injection, and Bevacizumab injection [2] - 恒瑞医药 (01276.HK) has also received approval to conduct clinical trials for HRS-5041, intended for prostate cancer treatment [2] - 深圳高速公路股份 (00548.HK) reported toll revenue of 106 million yuan for the outer ring project in June [2] - 大成生化科技 (00809.HK) has signed an EPC contract with Northeast Electric and Liaoning Electric for boiler renovation projects, with a maximum cost of 129.1 million yuan [2] - 小黄鸭德盈 (02250.HK) has signed a contract to develop an AI marketing system to diversify revenue sources [2] Buyback and Financing Activities - 威海银行 (09677.HK) plans to issue up to approximately 758 million domestic shares and 154 million H-shares, raising nearly 3 billion yuan [2] Financial Results - 香港电讯-SS (06823.HK) reported total revenue of 17.322 billion HKD for the first half, a year-on-year increase of 4%, with a net profit of 2.07 billion HKD, also up 4% [4] - 青岛银行 (03866.HK) reported operating revenue of 7.662 billion yuan for the first half, a growth of 7.5%, and a net profit of 3.065 billion yuan, up 16.05% [4] - 中国石油化工股份 (00386.HK) expects mid-term net profit to be between 20.1 billion and 21.6 billion yuan, a year-on-year decline of 39.5%-43.7% [4] - 汽车之家-S (02518.HK) reported total revenue of 3.212 billion yuan for the first half, a decrease of 7.75%, with a net profit of 772 million yuan, down 15.99% [4] - 绿茶集团 (06831.HK) issued a profit warning, expecting mid-term net profit to be between 230 million and 237 million yuan, a year-on-year increase of approximately 32%-36% [4] - 粤海置地 (00124.HK) issued a profit warning, expecting mid-term net profit to exceed 260 million HKD, turning from loss to profit [4] - 药师帮 (09885.HK) issued a profit warning, expecting mid-term net profit to exceed 70 million yuan [4] - 中国东方教育 (00667.HK) issued a profit warning, expecting mid-term net profit to grow by 45%-50% year-on-year [4] - 中核国际 (02302.HK) issued a profit warning, expecting mid-term revenue to increase to at least 585 million HKD, with net profit of at least 9.5 million HKD [4] - 大唐环境 (01272.HK) issued a profit warning, expecting mid-term net profit to decrease to between 350 million and 400 million yuan [4] - 长江生命科技 (00775.HK) issued a profit warning, expecting mid-term net loss of approximately 150 million HKD, turning from profit to loss year-on-year [4] - 延长石油国际 (00346.HK) issued a profit warning, expecting mid-term loss of approximately 27.9 million HKD [4]